Systematic review / meta-analysis / 2024
Curcumin or turmeric supplementation significantly reduced AST, ALT, HOMA-IR, BMI, and waist circumference in NAFLD patients.
An umbrella meta-analysis analyzed 11 meta-analyses covering 99 randomized controlled trials with 5,546 participants to determine the effects of curcumin/turmeric supplementation in non-alcoholic fatty liver disease. Supplementation significantly reduced AST (ES = -1.072, 95% CI: -1.656, -0.488, p = 0.000), ALT (ES = -0.625, 95% CI: -1.170, -0.134, p = 0.014), HOMA-IR (ES = -0.291, 95% CI: -0.368, -0.214, p = 0.000), BMI (ES = -0.205, 95% CI: -0.304, -0.107, p = 0.000), and waist circumference (ES = -1.290, 95% CI: -2.038, -0.541, p = 0.001). TG was reported with ES = -0.469 (95% CI: -1.057, 0.119, p = 0.128), while effects on GGT, ALP, TC, LDL-C, HDL-C, FBS, HbA1C, and body weight were not significant.
- Study type
- Umbrella meta-analysis of randomized controlled trials
- Who was studied
- 5,546 participants across 99 randomized controlled trials from 11 meta-analyses
- What was measured
- Liver enzymes, lipid profiles, glycemic markers, and anthropometric indices
THE PAPER
Effects of curcumin/turmeric supplementation on the liver enzymes, lipid profiles, glycemic index, and anthropometric indices in non-alcoholic fatty liver patients: An umbrella meta-analysis.
Molani-Gol R, Dehghani A, Rafraf M. Phytother Res, 2024.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.